Last Updated: August 7, 2026

Suppliers and packagers for DIANEAL PD-2 W/ DEXTROSE 2.5% IN PLASTIC CONTAINER


✉ Email this page to a colleague

« Back to Dashboard


DIANEAL PD-2 W/ DEXTROSE 2.5% IN PLASTIC CONTAINER

Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.

Applicant Tradename Generic Name Dosage NDA NDA/ANDA Supplier Package Code Package Marketing Start
Vantive Us Hlthcare DIANEAL PD-2 W/ DEXTROSE 2.5% IN PLASTIC CONTAINER calcium chloride; dextrose; magnesium chloride; sodium chloride; sodium lactate SOLUTION;INTRAPERITONEAL 017512 NDA Vantive US Healthcare LLC 0941-0409-01 6000 mL in 1 BAG (0941-0409-01) 1978-09-27
Vantive Us Hlthcare DIANEAL PD-2 W/ DEXTROSE 2.5% IN PLASTIC CONTAINER calcium chloride; dextrose; magnesium chloride; sodium chloride; sodium lactate SOLUTION;INTRAPERITONEAL 017512 NDA Vantive US Healthcare LLC 0941-0409-05 3000 mL in 1 BAG (0941-0409-05) 1978-09-27
Vantive Us Hlthcare DIANEAL PD-2 W/ DEXTROSE 2.5% IN PLASTIC CONTAINER calcium chloride; dextrose; magnesium chloride; sodium chloride; sodium lactate SOLUTION;INTRAPERITONEAL 017512 NDA Vantive US Healthcare LLC 0941-0409-06 2000 mL in 1 BAG (0941-0409-06) 1978-09-27
Vantive Us Hlthcare DIANEAL PD-2 W/ DEXTROSE 2.5% IN PLASTIC CONTAINER calcium chloride; dextrose; magnesium chloride; sodium chloride; sodium lactate SOLUTION;INTRAPERITONEAL 017512 NDA Vantive US Healthcare LLC 0941-0409-07 5000 mL in 1 BAG (0941-0409-07) 1978-09-27
>Applicant >Tradename >Generic Name >Dosage >NDA >NDA/ANDA >Supplier >Package Code >Package >Marketing Start

Suppliers for DIANEAL PD-2 (Dextrose 2.5%) in Plastic Container

Last updated: May 11, 2026

Who manufactures DIANEAL PD-2 (Dextrose 2.5% in a plastic container)?

DIANEAL PD-2 is a Baxter-branded peritoneal dialysis solution (dextrose 2.5%) supplied by Baxter Healthcare Corporation (the product is marketed as DIANEAL® for peritoneal dialysis). The supplier of record for the branded product is Baxter.

Which companies are documented suppliers in the distribution chain?

Public labeling and trade distribution for DIANEAL is typically structured as:

  • Manufacturer / brand owner: Baxter Healthcare Corporation
  • US distribution channel: Authorized pharmaceutical distributors supplying hospital and dialysis networks (varies by geography, contract, and tender cycle)

No other named manufacturer is listed for the branded DIANEAL PD-2 formulation in the standard US product labeling context.

What packaging and “plastic container” supplier implications matter?

DIANEAL PD-2 in plastic containers is a Baxter-packaged formulation used for peritoneal dialysis. Supplier implications for sourcing the same product depend on:

  • Same brand and strength: DIANEAL PD-2 with dextrose 2.5%
  • Same dosage form: peritoneal dialysis solution
  • Same container type: plastic container (not glass)

Where a supplier substitutes container formats or dextrose strengths (e.g., 1.5% or 4.25%), the SKU becomes different even if it is the same clinical category.

What is the practical supplier list for procurement?

Procurement for branded DIANEAL PD-2 typically targets two layers:

1) Brand manufacturer (primary supplier)

  • Baxter Healthcare Corporation (DIANEAL® PD-2 2.5% dextrose in plastic container)

2) Authorized distributors (secondary suppliers)

  • Hospital and dialysis purchasing is executed through contract distributors. The set of distributors changes by region and contract, and DIANEAL SKUs are allocated through those channels rather than through alternate manufacturers.

What procurement-facing supplier identifiers should buyers match?

Buyers should confirm the following on purchase orders and invoices:

  • Brand: DIANEAL®
  • Strength: 2.5% dextrose
  • Product: PD-2
  • Container: plastic container
  • Manufacturer on labeling: Baxter Healthcare Corporation

How to treat “equivalent” supplier offers in bidding

If another vendor offers “dextrose peritoneal dialysis solution 2.5%” but does not identify:

  • DIANEAL PD-2 specifically and
  • plastic container and
  • Baxter as the manufacturer on the label,

then it is not the same commercial product and can change both clinical compatibility and tender compliance.


Key Takeaways

  • Baxter Healthcare Corporation is the manufacturer/supplier of the branded DIANEAL® PD-2 formulation with dextrose 2.5% in plastic containers.
  • Other “supplier” entities in practice are authorized distribution partners that vary by geography and contract; they do not replace Baxter as the manufacturer of the branded product.
  • Procurement must match brand (DIANEAL), PD-2, dextrose 2.5%, and plastic container to avoid SKU substitutions.

FAQs

1) Can a generic manufacturer supply the same DIANEAL PD-2 SKU under a different name?

No. DIANEAL PD-2 is a Baxter-branded product; substitution by alternate manufacturers is not the same commercial SKU unless it is explicitly the same branded product.

2) Are the suppliers different for plastic versus non-plastic containers?

The manufacturer remains Baxter for the branded DIANEAL product line, but the commercial SKU differs by container format, so distributors may show different line items for plastic versus other packaging types.

3) Do distributors change by hospital system and region?

Yes. Authorized distributors supplying DIANEAL vary based on distribution contracts and regional procurement channels.

4) What should buyers verify to ensure the correct sourcing?

Verify DIANEAL®, PD-2, 2.5% dextrose, and plastic container, and confirm the manufacturer name on the label is Baxter.

5) Does “2.5% dextrose peritoneal dialysis solution” guarantee it is DIANEAL PD-2?

No. Matching dextrose strength alone is not sufficient. The product must be DIANEAL PD-2 with the plastic container format.


References

[1] Baxter Healthcare Corporation. DIANEAL® PD-2 (dextrose 2.5%) peritoneal dialysis solution: product labeling and prescribing information.

More… ↓

⤷  Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.